Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron ± dexamethasone vs tolansetron + dexamethasone for prevention of postoperative nausea and vomiting in children undergoing adenotonsillectomy
ChiCTR2100046848Phase 4Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of palonosetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Postoperative nausea and vomiting. Started Jun 2021; status: recruiting.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2100046848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046848.